NAB-14（Cat No.:I032983）is a small molecule inhibitor primarily investigated for its potential therapeutic applications in cancer and inflammation. It works by targeting specific proteins or signaling pathways that regulate cell growth, survival, and immune response. NAB-14 has shown promise in preclinical studies for its ability to suppress tumor growth and modulate the immune microenvironment, potentially enhancing the effectiveness of immunotherapies. By disrupting key molecular processes in cancer and inflammatory conditions, NAB-14 holds potential as a targeted treatment strategy for a range of diseases, warranting further clinical investigation.